Editorial introductions
Do implantable cardioverter defibrillators complicate end-of-life care for those with heart failure?
Addressing ‘the elephant on the table’
Multidsciplinary heart failure management and end of life care
Heart failure comorbidities at the end of life
Understanding cancer-induced cachexia
Targeting the myostatin signaling pathway to treat muscle wasting diseases
The advantages and limitations of cross-sectional body composition analysis
Cachexia assessment tools
Lipid mobilization in cachexia
Improving muscle mass and function in cachexia
Current World Literature
Mitochondria and heart failure